DOCSLIB.ORG

Unique Concatenate (Description)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Unique Concatenate (Description) Unique Concatenate (Description) Sequence Variable modifications ([position] description) CP-690,550_1CP-690,550_2NVP-BSK805_1NVP-BSK805_2NVP-BBT594 123 ABI1 Isoform 1 of Abl interactor 1 TLEPVKPPTVPNDYMTSPAR [14] Phospho (Y) 5.355704 -0.70208 ABL1 Isoform IA of Proto-oncogene tyrosine-protein kinase ABL1 LMTGDTYTAHAGAK [7] Phospho (Y) -1.08927 -1.09868 -3.96523 ACLY ATP-citrate synthase TTDGVYEGVAIGGDR [6] Phospho (Y) 0.252136 ACSM3 SA hypertension-associated homolog isoform 1 LGIPEYFNFAK [6] Phospho (Y) -0.44989 1.66553 ACTB Actin, cytoplasmic 1 GYSFTTTAER [2] Phospho (Y) 1.066328 -0.37053 -0.0692 ACTB Actin, cytoplasmic 1 KDLYANTVLSGGTTMYPGIADR [4] Phospho (Y) -0.97756 0.141466 1.200179 -1.01433 -1.19347 AGPS Alkyldihydroxyacetonephosphate synthase, peroxisomal precursor IRPVPEYQK [7] Phospho (Y) -0.39593 ALDH1A1 Retinal dehydrogenase 1 ANNTFYGLSAGVFTK [6] Phospho (Y) -0.02661 -1.93143 ALDOA Fructose-bisphosphate aldolase A PYQYPALTPEQK [2] Phospho (Y) 8.071839 -0.26633 ANXA2P2 Putative annexin A2-like protein LSLEGDHSTPPSAYGSVK [14] Phospho (Y) -1.49415 -2.13203 -2.06654 ANXA5 Annexin A5 LYDAYELK [5] Phospho (Y) -0.42726 7.051289 -1.37202 ATP1A1 Isoform Short of Sodium/potassium-transporting ATPase subunit alpha-1 GIVVYTGDR [5] Phospho (Y) -0.32719 BTK Tyrosine-protein kinase BTK HYVVCSTPQSQYYLAEK [12] Phospho (Y) -4.27596 BTK Tyrosine-protein kinase BTK VVALYDYMPMNANDLQLR [6] Phospho (Y)|[9] Oxidation (M)|[11] Oxidation (M) -2.48212 -1.06083 C11orf59 UPF0404 protein C11orf59 ALNGAEPNYHSLPSAR [9] Phospho (Y) -0.52861 -0.97348 C20orf4 Chromosome 20 open reading frame 4 YHHTRLINNNK [1] Phospho (Y) 2.690111 3.194396 CALM3;CALM1;CALM2 Calmodulin VFDKDGNGYISAAELR [9] Phospho (Y) -0.31646 -1.01067 CASKIN2 Caskin-2, CASKIN2 cask-interacting protein 2 isoform b NTYNQTALDIVNQFTTSQASR [3] Phospho (Y) -0.66462 0.30439 -8.69058 -1.72382 CD200R1 Isoform 1 of Cell surface glycoprotein OX2 receptor precursor NNPLYDTTNKVK [5] Phospho (Y) -0.97152 CD46 Isoform B of Membrane cofactor protein precursor ADGGAEYATYQTK [7] Phospho (Y) -7.71141 CD7 T-cell antigen CD7 precursor NSAACVVYEDMSHSR [8] Phospho (Y) -14.2794 CD84 Isoform 1 of SLAM family member 5 EEPVNTVYSEVQFADK [8] Phospho (Y) -1.95734 CD84 Isoform 1 of SLAM family member 5 IYDEILQSK [2] Phospho (Y) 0.536556 -2.08589 CD84 Isoform 3 of SLAM family member 5 precursor NTQPAESRIYDEILQSK [10] Phospho (Y) -0.24571 CD84 Isoform 3 of SLAM family member 5 precursor VLPSKEEPVNTVYSEVQFADKMGK [13] Phospho (Y)|[22] Oxidation (M) -0.57507 CD84 Isoform 3 of SLAM family member 5 precursor TIYTYIMASR [3] Phospho (Y) -0.20232 CDC2 cell division cycle 2 isoform 3 IGEGTYGVVYK [5] Phospho (ST)|[6] Phospho (Y) -0.0014 0.327054 1.513428 -0.69591 0.01604 CDC2 cell division cycle 2 isoform 3 IGEGTYGVVYK [6] Phospho (Y) 0.431667 2.004094 -1.22784 0.083731 CDC2 Putative uncharacterized protein DKFZp686L20222 IGEGTYGVVYKGR [10] Phospho (Y) -1.27904 CDC2 Putative uncharacterized protein DKFZp686L20222 IEKIGEGTYGVVYK [8] Phospho (ST)|[9] Phospho (Y) 0.47981 CDK3 28 kDa protein VEKIGEGTYGVVYK [9] Phospho (Y) -0.11638 -1.8478 CDK3 28 kDa protein VEKIGEGTYGVVYK [8] Phospho (ST)|[9] Phospho (Y) -1.85595 CDK5 Cell division protein kinase 5 IGEGTYGTVFK [6] Phospho (Y) -0.10728 0.126843 4.938536 -1.04675 -0.0392 CDV3 Protein CDV3 homolog KTPQGPPEIYSDTQFPSLQSTAK [10] Phospho (Y) -1.71463 CFL1 Cofilin-1 HELQANCYEEVKDR [8] Phospho (Y) -0.3083 0.002106 -0.90602 7.093369 CTNND1 Isoform 1AB of Catenin delta-1 LNGPQDHSHLLYSTIPR [12] Phospho (Y) -0.84094 -0.0431 0.711454 -1.36468 DBNL cDNA FLJ54071, highly similar to Drebrin-like protein FQDVGPQAPVGSVYQK [14] Phospho (Y) 0.262679 DDX3Y ATP-dependent RNA helicase DDX3Y ELAVQIYEEAR [7] Phospho (Y) -1.08366 DLG1 cDNA FLJ50509, highly similar to Disks large homolog 1 DYHFVTSR [2] Phospho (Y) -0.9464 DLG1 cDNA FLJ50509, highly similar to Disks large homolog 1 NTSDFVYLK [7] Phospho (Y) 0.324479 5.435575 -0.63069 -0.83091 DOK1 Isoform 1 of Docking protein 1 SHNSALYSQVQK [7] Phospho (Y) -1.152 -2.33376 1.599043 DOK2 28 kDa protein GQEGEYAVPFDAVAR [6] Phospho (Y) -3.21492 DYRK1A Isoform Long of Dual specificity tyrosine-phosphorylation-regulated kinase 1A IYQYIQSR [4] Phospho (Y) -0.57363 -0.22623 -0.98415 -0.52882 DYRK1B Isoform 1 of Dual specificity tyrosine-phosphorylation-regulated kinase 1B IYQYIQSR [2] Phospho (Y)|[4] Phospho (Y) DYRK2 Isoform 2 of Dual specificity tyrosine-phosphorylation-regulated kinase 2 VYTYIQSR [4] Phospho (Y) -0.15779 -0.76196 EEF1A1 Elongation factor 1-alpha 1 STTTGHLIYK [4] Phospho (ST)|[9] Phospho (Y) -0.47516 EEF1A1 Elongation factor 1-alpha 1, EEF1A2 Elongation factor 1-alpha 2 STTTGHLIYK [9] Phospho (Y) 0.584593 0.966683 -0.83149 -0.91196 -1.18194 EEF1A1 Elongation factor 1-alpha 1, EEF1A2 Elongation factor 1-alpha 2 EHALLAYTLGVK [7] Phospho (Y) -1.27079 -0.05857 0.549921 -0.74632 -0.50617 EIF3C Eukaryotic translation initiation factor 3 subunit 8 QGTYGGYFR [4] Phospho (Y) -0.46691 ELAVL1 cDNA FLJ60076, highly similar to ELAV-like protein 1, ELAVL1 ELAV-like protein 1 NVALLSQLYHSPAR [9] Phospho (Y) -0.9972 0.093658 EML4 109 kDa protein DVIINQEGEYIK [10] Phospho (Y) -0.37037 ENO1 Isoform alpha-enolase of Alpha-enolase, ENO2 Gamma-enolase AAVPSGASTGIYEALELR [12] Phospho (Y) -0.51482 0.639151 -1.43083 -4.96234 -1.36664 FCER1G High affinity immunoglobulin epsilon receptor subunit gamma precursor NQETYETLKHEKPPQ [5] Phospho (Y) 0.713508 FCER1G High affinity immunoglobulin epsilon receptor subunit gamma precursor SDGVYTGLSTR [5] Phospho (Y) -0.5158 FLNA Isoform 2 of Filamin-A VANPSGNLTETYVQDR [12] Phospho (Y) -0.48688 FYB cDNA FLJ56106, highly similar to Homo sapiens FYN binding protein (FYB-120/130) (FYB), transcript variant 1, mRNA TTAVEIDYDSLK [8] Phospho (Y) -4.35083 G6PD Isoform 3 of Glucose-6-phosphate 1-dehydrogenase, G6PD Isoform Long of Glucose-6-phosphate 1-dehydrogenase VQPNEAVYTK [8] Phospho (Y) 1.83137 0.914726 -0.0786 -0.7483 G6PD Isoform Long of Glucose-6-phosphate 1-dehydrogenase VGFQYEGTYK [5] Phospho (Y) -0.31235 10.20613 GAB1 Isoform 1 of GRB2-associated-binding protein 1 VDYVVVDQQK [3] Phospho (Y) -14.0887 -3.14436 GAB3 Gab3 protein isoform 2, GAB3 GRB2-associated-binding protein 3 VDYVQVDEQK [3] Phospho (Y) -3.79124 -2.47187 GADD45GIP1 Growth arrest and DNA-damage-inducible proteins-interacting protein 1 LQAEAQELLGYQVDPR [11] Phospho (Y) 0.083527 GLUD1 Glutamate dehydrogenase 1, mitochondrial precursor DIVHSGLAYTMER [9] Phospho (Y) -0.16511 GRIN3B Glutamate [NMDA] receptor subunit 3B precursor SPYGLTPR [3] Phospho (Y) 0.942246 GRLF1 Isoform 1 of Glucocorticoid receptor DNA-binding factor 1 NEEENIYSVPHDSTQGK [7] Phospho (Y) -0.92437 -0.08102 -1.1288 -0.40768 -1.56857 GSK3B Isoform 1 of Glycogen synthase kinase-3 beta, GSK3B Isoform 2 of Glycogen synthase kinase-3 beta GEPNVSYICSR [7] Phospho (Y) -3.20664 0.141224 1.917476 -1.38125 1.00988 HCK Isoform p59-HCK of Tyrosine-protein kinase HCK, LYN LYN protein VIEDNEYTAR [7] Phospho (Y) 1.223473 -1.79277 -3.04758 -2.78579 -2.28853 HGS Hepatocyte growth factor-regulated tyrosine kinase substrate VCEPCYEQLNR [6] Phospho (Y) 0.692502 -1.41224 13.58083 highly similar to Protein FAM62A, FAM62A Isoform 1 of Protein FAM62A HLSPYATLTVGDSSHK [5] Phospho (Y) 0.213155 -0.30571 -0.56411 -1.25265 -0.52628 HIPK2 Isoform 2 of Homeodomain-interacting protein kinase 2 AVCSTYLQSR [6] Phospho (Y) -2.6677 -0.26957 -0.88923 3.723079 1.850637 HIPK3 Isoform 1 of Homeodomain-interacting protein kinase 3 TVCSTYLQSR [6] Phospho (Y) -4.20046 -0.33912 10.07687 Histone H4 ISGLIYEETR [6] Phospho (Y) 1.889759 -0.65143 HNRNPUL1 Isoform 3 of Heterogeneous nuclear ribonucleoprotein U-like protein 1 NYILDQTNVYGSAQR [10] Phospho (Y) -0.17736 HNRPH3 Isoform 1 of Heterogeneous nuclear ribonucleoprotein H3 DGMDNQGGYGSVGR [9] Phospho (Y) -0.35469 HP1BP3 HP1-BP74 YVLENHPGTNSNYQMHLLK [13] Phospho (Y) 0.691043 0.221112 HSP90AA1 heat shock protein 90kDa alpha (cytosolic), class A member 1 isoform 1, HSP90AA1 Isoform 2 of Heat shock protein HSPHIYYITGETK 90-alpha [3] Phospho (Y) 0.242089 -1.17485 12.93448 -1.49071 HSP90AB1 85 kDa protein, HSP90AB1 Heat shock protein HSP 90-beta SIYYITGESK [3] Phospho (Y) -7.63328 0.176399 5.402169 -1.16501 -0.58425 HSPA4 Heat shock 70 kDa protein 4 EDIYAVEIVGGATR [7] Phospho (Y) -0.10706 8.556799 -0.8709 -0.39919 HSPD1 61 kDa protein GYISPYFINTSK [6] Phospho (Y) -1.29534 2.848181 -1.22373 HSPE1 10 kDa heat shock protein, mitochondrial VLLPEYGGTK [6] Phospho (Y) -0.47895 INPP5D Isoform 1 of Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1 LYDFVK [2] Phospho (Y) 0.254142 -0.41422 4.635418 -1.17819 -1.85141 IQGAP1 Ras GTPase-activating-like protein IQGAP1 LQQTYAALNSK [5] Phospho (Y) -0.99546 IRS2 Insulin receptor substrate 2 insertion mutant SDDYMPMSPASVSAPK [4] Phospho (Y) 0.72808 -0.78856 IRS2 Insulin receptor substrate 2 insertion mutant TYSLTTPAR [2] Phospho (Y) -1.39235 Isoform 1 of Glutamate receptor, ionotropic kainate 1 precursor EYTSIK [2] Phospho (Y)|[4] Phospho (ST) 3.588246 Isoform 4 of Protein NLRC3 MDQEYFVYK [1] Oxidation (M)|[5] Phospho (Y) 0.75746 -1.8608 ISYNA1 55 kDa protein VGPVAATYPMLNK [8] Phospho (Y) -2.29052 ITSN2 Isoform 3 of Intersectin-2, ITSN2 Isoform 4 of Intersectin-2 LIYLVPEK [3] Phospho (Y) -0.48395 0.47634 2.63617 -1.12661 -2.495 ITSN2 Isoform 3 of Intersectin-2, ITSN2 Isoform 4 of Intersectin-2 REEPEALYAAVNK [8] Phospho (Y) 3.189777 -1.12323 -1.00256 JAK2 Tyrosine-protein kinase JAK2 VLPQDKEYYK [8] Phospho (Y) 5.339293 3.579495 3.941952 6.949275 -0.88496 JAK2 Tyrosine-protein kinase JAK2 VLPQDKEYYK [8] Phospho (Y)|[9] Phospho (Y) -2.16418 JAK2 Tyrosine-protein
Load more

Recommended publications
  • Supplemental Information IRF4 Transcription Factor-Dependent Cd11b+ Dendritic Cells in Human and Mouse Control Mucosal IL-17 C
    Immunity, Volume 38 Supplemental Information IRF4 Transcription Factor-Dependent CD11b+ Dendritic Cells in Human and Mouse Control Mucosal IL-17 Cytokine Responses Andreas Schlitzer, Naomi McGovern, Pearline Teo, Teresa Zelante, Koji Atarashi, Donovan Low, Adrian W.S. Ho, Peter See, Amanda Shin, Pavandip Singh Wasan, Guillaume Hoeffel, Benoit Malleret, Alexander Heiseke, Samantha Chew, Laura Jardine, Harriet A. Purvis, Catharien M.U. Hilkens, John Tam, Michael Poidinger, E. Richard Stanley, Anne B. K rug, Laurent Renia, Baalasubramanian Sivasankar, Lai Guan Ng, Matthew Collin, Paola Ricciardi-Castagnoli, Kenya Honda, Muzlifah Haniffa, and Florent Ginhoux Supplemental Inventory 1. Supplemental Figures and Tables Figure S1, Related to Figure 1 Figure S2, Related to Figure 2 and 3 Figure S3, Related to Figure 4 Figure S4, Related to Figure 5 Figure S5, Related to Figure 5 Figure S6, Related to Figure 7 Table S1, Related to Figure 3 Table S2, Related to Figure 6 Table S3, Related to Figure 6 2. Supplemental Experimental Procedures 3. Supplemental References Supplementary figure 1 Sorting strategy for mouse lung and small intestinal DC A Sorting strategy, Lung Singlets Dapi-CD45+ 250K 250K 250K 105 200K 200K 200K 104 A I - 150K 150K 150K C P C C 3 10 S A S S 100K 100K S 100K D S S 102 50K 50K 50K 0 0 0 0 0 50K 100K 150K 200K 250K 0 50K 100K 150K 200K 250K 0 103 104 105 0 103 104 105 FSC FSC-W CD45 GR1 Auto Fluor.- MHCII+ GR1- SSClow CD11c+ CD11b+ 250K 105 105 105 200K 4 104 10 104 150K I 3 I 3 4 3 0 10 3 C 2 H 10 10 100K 1 S D C D S C M 2 C 10 50K 0 0 0 0 0 102 103 104 105 0 103 104 105 0 103 104 105 0 103 104 105 Auto fluor.
    [Show full text]
  • A Human Population-Based Organotypic in Vitro Model for Cardiotoxicity Screening1
    ALTEX preprint published July 8, 2018 doi:10.14573/altex.1805301 Research Article A human population-based organotypic in vitro model for cardiotoxicity screening1 Fabian A. Grimm1, Alexander Blanchette1, John S. House2, Kyle Ferguson1, Nan-Hung Hsieh1, Chimeddulam Dalaijamts1, Alec A. Wright1, Blake Anson5, Fred A. Wright3,4, Weihsueh A. Chiu1, Ivan Rusyn1 1Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX, USA; 2Bioinformatics Research Center, 3Department of Biological Sciences, and 4Department of Statistics, North Carolina State University, Raleigh, NC, USA; 5Cellular Dynamics International, Madison, WI, USA Abstract Assessing inter-individual variability in responses to xenobiotics remains a substantial challenge, both in drug development with respect to pharmaceuticals and in public health with respect to environmental chemicals. Although approaches exist to characterize pharmacokinetic variability, there are no methods to routinely address pharmacodynamic variability. In this study, we aimed to demonstrate the feasibility of characterizing inter-individual variability in a human in vitro model. Specifically, we hypothesized that genetic variability across a population of iPSC- derived cardiomyocytes translates into reproducible variability in both baseline phenotypes and drug responses. We measured baseline and drug-related effects in iPSC-derived cardiomyocytes from 27 healthy donors on kinetic Ca2+ flux and high-content live cell imaging. Cells were treated in concentration-response with cardiotoxic drugs: isoproterenol (β- adrenergic receptor agonist/positive inotrope), propranolol (β-adrenergic receptor antagonist/negative inotrope), and cisapride (hERG channel inhibitor/QT prolongation). Cells from four of the 27 donors were further evaluated in terms of baseline and treatment-related gene expression. Reproducibility of phenotypic responses was evaluated across batches and time.
    [Show full text]
  • Gene Expression of Osteosarcoma Cells on Various Coated Titanium Materials
    MOLECULAR & CELLULAR TOXICOLOGY, Vol. 3, No. 1, 36-45, March 2007 Gene Expression of Osteosarcoma Cells on Various Coated Titanium Materials Sung-Hwa Sohn1, Jae Bun Lee2, Ki-Nam Kim1, are made with Ti alloys. However, the exact effect of In Kyoung Kim1, Seung Ho Lee1, Hye Won Kim1, Ti on osteoblasts is still unknown2-4. Successful ap- Sang-Hui Seo1, Yu-Ri Kim1, Sang-Wan Shin2, plication of such materials for bone regeneration Jae-Jun Ryu2 & Meyoung-Kon Kim1 often involved mixing with autogenous bone, a sour- ce of osteoblastic cells and precursors2. 1Department of Biochemistry & Molecular Biology Surface topography may affect the formation of a 2Department of Dentistry, College of Medicine, Korea University, fibrous capsule around implants, inflammatory res- Seoul 136-705, Korea ponse at tissue-implant interface, fibroblast attach- Correspondence and requests for materials should be addressed ment, angiogenesis, epithelial down-growth around to M-K. Kim ([email protected]) percutaneous devices, and many cellular processes such as cellular differentiation, transcription, cell Accepted 8 March 2007 metabolism, protein production, and phenotypic ex- pression1,3,5-7. Diverse implant surface may contribute to the regulation of osteoblast differentiation by infl- Abstract uencing the level of gene expression of key osteo- genic factors7,8. Morphometric analyses had shown Several features of the implant surface, such as differences in bone-implant contact percentages with topography, roughness, and composition play a the varying of surface characteristics, as well as a relevant role in implant integration with bone. This sensitivity of cells to surface topography9,10. Gene ex- study was conducted in order to determine the pression in response to the placement of implants effects of different-coatings on Ti surfaces on the with different surface topographies11-16.
    [Show full text]
  • Anti-Inflammatory Role of Curcumin in LPS Treated A549 Cells at Global Proteome Level and on Mycobacterial Infection
    Anti-inflammatory Role of Curcumin in LPS Treated A549 cells at Global Proteome level and on Mycobacterial infection. Suchita Singh1,+, Rakesh Arya2,3,+, Rhishikesh R Bargaje1, Mrinal Kumar Das2,4, Subia Akram2, Hossain Md. Faruquee2,5, Rajendra Kumar Behera3, Ranjan Kumar Nanda2,*, Anurag Agrawal1 1Center of Excellence for Translational Research in Asthma and Lung Disease, CSIR- Institute of Genomics and Integrative Biology, New Delhi, 110025, India. 2Translational Health Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067, India. 3School of Life Sciences, Sambalpur University, Jyoti Vihar, Sambalpur, Orissa, 768019, India. 4Department of Respiratory Sciences, #211, Maurice Shock Building, University of Leicester, LE1 9HN 5Department of Biotechnology and Genetic Engineering, Islamic University, Kushtia- 7003, Bangladesh. +Contributed equally for this work. S-1 70 G1 S 60 G2/M 50 40 30 % of cells 20 10 0 CURI LPSI LPSCUR Figure S1: Effect of curcumin and/or LPS treatment on A549 cell viability A549 cells were treated with curcumin (10 µM) and/or LPS or 1 µg/ml for the indicated times and after fixation were stained with propidium iodide and Annexin V-FITC. The DNA contents were determined by flow cytometry to calculate percentage of cells present in each phase of the cell cycle (G1, S and G2/M) using Flowing analysis software. S-2 Figure S2: Total proteins identified in all the three experiments and their distribution betwee curcumin and/or LPS treated conditions. The proteins showing differential expressions (log2 fold change≥2) in these experiments were presented in the venn diagram and certain number of proteins are common in all three experiments.
    [Show full text]
  • Sex-Dependent Differences in the Secretome of Human Endothelial Cells Maria Grazia Cattaneo1*†, Cristina Banfi2†, Maura Brioschi2, Donatella Lattuada1 and Lucia M
    Cattaneo et al. Biology of Sex Differences (2021) 12:7 https://doi.org/10.1186/s13293-020-00350-3 RESEARCH Open Access Sex-dependent differences in the secretome of human endothelial cells Maria Grazia Cattaneo1*†, Cristina Banfi2†, Maura Brioschi2, Donatella Lattuada1 and Lucia M. Vicentini1 Abstract Background: Cellular sex has rarely been considered as a biological variable in preclinical research, even when the pathogenesis of diseases with predictable sex differences is studied. In this perspective, proteomics, and “omics” approaches in general, can provide powerful tools to obtain comprehensive cellular maps, thus favoring the discovery of still unknown sex-biased physio-pathological mechanisms. Methods: We performed proteomic and Gene Ontology (GO) analyses of the secretome from human serum- deprived male and female endothelial cells (ECs) followed by ELISA validation. Apoptosis was detected by FACS and Western blot techniques and efferocytosis through the ability of the macrophage cell line RAW 264.7 to engulf apoptotic ECs. PTX3 mRNA levels were measured by RT-qPCR. Results: Proteomic and GO analyses of the secretome from starved human male and female ECs demonstrated a significant enrichment in proteins related to cellular responses to stress and to the regulation of apoptosis in the secretome of male ECs. Accordingly, a higher percentage of male ECs underwent apoptosis in response to serum deprivation in comparison with female ECs. Among the secreted proteins, we reliably found higher levels of PTX3 in the male EC secretome. The silencing of PTX3 suggested that male ECs were dependent on its expression to properly carry out the efferocytotic process. At variance, female EC efferocytosis seemed to be independent on PTX3 expression.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • New Approach for Untangling the Role of Uncommon Calcium-Binding Proteins in the Central Nervous System
    brain sciences Review New Approach for Untangling the Role of Uncommon Calcium-Binding Proteins in the Central Nervous System Krisztina Kelemen * and Tibor Szilágyi Department of Physiology, Doctoral School, Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Târgu Mures, , Romania; [email protected] * Correspondence: [email protected]; Tel.: +40-746-248064 Abstract: Although Ca2+ ion plays an essential role in cellular physiology, calcium-binding proteins (CaBPs) were long used for mainly as immunohistochemical markers of specific cell types in different regions of the central nervous system. They are a heterogeneous and wide-ranging group of proteins. Their function was studied intensively in the last two decades and a tremendous amount of informa- tion was gathered about them. Girard et al. compiled a comprehensive list of the gene-expression profiles of the entire EF-hand gene superfamily in the murine brain. We selected from this database those CaBPs which are related to information processing and/or neuronal signalling, have a Ca2+- buffer activity, Ca2+-sensor activity, modulator of Ca2+-channel activity, or a yet unknown function. In this way we created a gene function-based selection of the CaBPs. We cross-referenced these findings with publicly available, high-quality RNA-sequencing and in situ hybridization databases (Human Protein Atlas (HPA), Brain RNA-seq database and Allen Brain Atlas integrated into the HPA) and created gene expression heat maps of the regional and cell type-specific expression levels of the selected CaBPs. This represents a useful tool to predict and investigate different expression patterns and functions of the less-known CaBPs of the central nervous system.
    [Show full text]
  • Original Article Potential Targets and Clinical Value of Mir-490-5P in Hepatocellular Carcinoma: a Study Based on TCGA, Qrt-PCR and Bioinformatics Analyses
    Int J Clin Exp Pathol 2018;11(3):1123-1134 www.ijcep.com /ISSN:1936-2625/IJCEP0070742 Original Article Potential targets and clinical value of miR-490-5p in hepatocellular carcinoma: a study based on TCGA, qRT-PCR and bioinformatics analyses Hong Yang1*, Lu Zhang2*, Xiao-Dong Wang1, Meng-Lan Huang2, Peng Lin1, Yu-Yan Pang2, Zhen-Bo Feng2, Gang Chen2 Departments of 1Medical Ultrasonics, 2Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China. *Equal contributors. Received December 11, 2017; Accepted January 7, 2018; Epub March 1, 2018; Published March 15, 2018 Abstract: Objective: To explore potential targets and clinical value of miR-490-5p in the oncogenesis and progres- sion of hepatocellular carcinoma (HCC). Methods: Clinical value of miR-490-5p was accessed through The Cancer Genome Atlas (TCGA) and qRT-PCR analyses. Potential target mRNAs of miR-490-5p were predicted by bioinfor- matics methods and were annotated as Gene Ontology (GO) function analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathway analysis, and Protein-Protein Interaction (PPI) network analysis. Results: miR- 490 expression in HCC tissues was lower compared with normal control tissues based on TCGA and down regula- tion of miR-490-5p was verified by qRT-PCR (P<0.0001). Both miR-490 and miR-490-5p had moderate ability to diagnose HCC tissues from noncancerous tissues. Moreover, lower miR-490 level predicted poorer overall survival in patients with HCC (P=0.0063). One hundred and eighty-four mRNAs were selected as potential targets of miR- 490-5p by overlap with 4,090 prediction genes and 1,478 differentially expressed genes (DEGs).
    [Show full text]
  • Molecular Characterization of Calreticulin Mutants Implicated in Sudden Unexplained Death
    Molecular Characterization of Calreticulin Mutants Implicated in Sudden Unexplained Death by Hector Vega A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science Department of Biochemistry University of Alberta © Hector Vega, 2018 Abstract Sudden unexplained death (SUD) is a term used when comprehensive medical examination and autopsy fail to find a conclusive cause of sudden death. In cases of SUD, post-mortem molecular and genetic evaluation methods have helped identify ion channel abnormalities leading to arrhythmias as cause. However, many cases of SUD remain unexplained by ion channel mutation evaluation. Using whole exome sequencing (WES) analysis, followed by strategic variant filtration, several mutations in the calreticulin gene (CALR) have been identified in cases of SUD. One of these mutations leads to an ultra-rare frame-shift in CALR, encoding a truncated mutant protein, CALR376fs. CALR is an endoplasmic reticulum (ER) Ca2+-binding protein and molecular chaperone for proper folding, assembly, and retention of secreted and membrane proteins, among several other functions. The involvement of CALR mutants in the SUD phenotype is puzzling and the mechanism is unknown. Molecular characterization of the CALR mutants compared to wild-type protein was performed, with focus on CALR376fs. It was found that the mutant proteins were folded different compared to wild-type CALR. Further analysis of CALR376fs indicated that it was also highly degraded and had impaired chaperone function. Traffic to the plasma membrane and activity of a Ca2+ ion channel linked to SUD has recently been found to be higher in presence of CALR376fs compared to wild-type protein.
    [Show full text]
  • Removal of Phospholamban Protects Ryr2-R4496C+/- CPVT Mutant
    Ca2+-Calmodulin Dependent Inactivation of Cardiac Ryanodine Receptor is a Major Determinant of Ca2+ Alternans in Intact Hearts Jinhong Wei1,a, Jinjing Yao1,b, Darrell Belke1, Wenting Guo1,c, Xiaowei Zhong1,c, Bo Sun1,b, Ruiwu Wang1, John Paul Estillore1, Alexander Vallmitjana2, Raul Benitez2,3, Leif Hove-Madsen4,, Enrique Alvarez-Lacalle5, Blas Echebarria5, and S.R. Wayne Chen1,d,* From the 1Libin Cardiovascular Institute, Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta T2N 4N1, Canada, 2Department of Automatic Control, Universitat Politècnica de Catalunya, 08034, Barcelona, Spain, 3Institut de Recerca Sant Joan de Déu (IRSJD), 08950, Barcelona, Spain; 4Biomedical Research Institute Barcelona IIBB-CSIC and IIB Sant Pau, Hospital de Sant Pau, 08025, Barcelona, Spain; and 5Departament de Física, Universitat Politècnica de Catalunya- Barcelona Tech, Barcelona, Spain Running Title: CaM Control of Ca2+ Alternans aJW, recipient of the Libin Cardiovascular Institute and Cumming School of Medicine Postdoctoral Fellowship Award. bJY, BS, recipients of the Alberta Innovates-Health Solutions (AIHS) Fellowship Award. cXZ, WG, recipients of the Alberta Innovates-Health Solutions (AIHS) Studentship Award. dSRWC, AIHS Scientist. *To whom correspondence should be addressed. S.R. Wayne Chen, 3330 Hospital Drive N.W., Calgary, Alberta, Canada, T2N 4N1. Tel.: 403-220-4235; e-mail: [email protected]; Blas Echebarria, [email protected]; Enrique Alvarez-Lacalle, [email protected]; or Leif Hove-Madsen, [email protected] Key words: Ventricular tachyarrhythmia, Ca2+ alternans, Ca2+ transient refractoriness, sarcoplasmic reticulum, cardiac ryanodine receptor, confocal Ca2+ imaging, intact heart imaging 1 ABSTRACT Rationale: Ca2+ alternans plays an essential role in cardiac alternans that can lead to ventricular fibrillation, but the mechanism underlying Ca2+ alternans remains undefined.
    [Show full text]
  • Zimmer Cell Calcium 2013 Mammalian S100 Evolution.Pdf
    Cell Calcium 53 (2013) 170–179 Contents lists available at SciVerse ScienceDirect Cell Calcium jo urnal homepage: www.elsevier.com/locate/ceca Evolution of the S100 family of calcium sensor proteins a,∗ b b,1 b Danna B. Zimmer , Jeannine O. Eubanks , Dhivya Ramakrishnan , Michael F. Criscitiello a Center for Biomolecular Therapeutics and Department of Biochemistry & Molecular Biology, University of Maryland School of Medicine, 108 North Greene Street, Baltimore, MD 20102, United States b Comparative Immunogenetics Laboratory, Department of Veterinary Pathobiology, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, TX 77843-4467, United States a r t i c l e i n f o a b s t r a c t 2+ Article history: The S100s are a large group of Ca sensors found exclusively in vertebrates. Transcriptomic and genomic Received 4 October 2012 data from the major radiations of mammals were used to derive the evolution of the mammalian Received in revised form 1 November 2012 S100s genes. In human and mouse, S100s and S100 fused-type proteins are in a separate clade from Accepted 3 November 2012 2+ other Ca sensor proteins, indicating that an ancient bifurcation between these two gene lineages Available online 14 December 2012 has occurred. Furthermore, the five genomic loci containing S100 genes have remained largely intact during the past 165 million years since the shared ancestor of egg-laying and placental mammals. Keywords: Nonetheless, interesting births and deaths of S100 genes have occurred during mammalian evolution. Mammals The S100A7 loci exhibited the most plasticity and phylogenetic analyses clarified relationships between Phylogenetic analyses the S100A7 proteins encoded in the various mammalian genomes.
    [Show full text]
  • An Efficient Method for Native Protein Purification in the Selected Range from Prostate Cancer Tissue Digests
    Original Article Page 1 of 7 An efficient method for native protein purification in the selected range from prostate cancer tissue digests Rumana Ahmad1,2, Carrie D. Nicora3, Anil K. Shukla3, Richard D. Smith3, Wei-Jun Qian3, Alvin Y. Liu1,2 1Department of Urology, University of Washington, Seattle, WA 98195, USA; 2Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98195, USA; 3Biological Science Division and Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, WA 99352, USA Contributions: (I) Conception and design: AY Liu; (II) Administrative support: AY Liu; (III) Provision of study materials or patients: R Ahmad; (IV) Collection and assembly of data: R Ahmad; (V) Data analysis and interpretation: R Ahmad, CD Nicora, AK Shukla, RD Smith, WJ Qian; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Rumana Ahmad. Department of Biochemistry, Era’s Lucknow Medical College & Hospital, Sarfarazganj, Hardoi Road, Lucknow-226003, UP, India. Email: [email protected]. Background: Prostate cancer (CP) cells differ from their normal counterpart in gene expression. Genes encoding secreted or extracellular proteins with increased expression in CP may serve as potential biomarkers. For their detection and quantification, assays based on monoclonal antibodies are best suited for development in a clinical setting. One approach to obtain antibodies is to use recombinant proteins as immunogen. However, the synthesis of recombinant protein for each identified candidate is time-consuming and expensive. It is also not practical to generate high quality antibodies to all identified candidates individually. Furthermore, non-native forms (e.g., recombinant) of proteins may not always lead to useful antibodies.
    [Show full text]